Form 4: Lemaitre Vascular Director Roberts Acquires Dividend Equivalent Rights
SEC Form 4 Filing
David B. Roberts, a director and officer at Lemaitre Vascular, acquired dividend equivalent rights related to restricted stock units and performance share units on March 27, 2025.
Summary
- On March 27, 2025, David B. Roberts, a director and officer of Lemaitre Vascular, acquired dividend equivalent rights.
- These rights are associated with previously granted restricted stock unit (RSU) and performance share unit (PSU) awards.
- The acquisitions include 0.8293 rights related to a 2020 RSU award, 1.5788 rights related to a 2021 RSU award, 3.2147 rights related to a 2022 RSU award, 3.2147 rights related to a 2022 PSU award, 4.1217 rights related to a 2023 RSU award, 4.9389 rights related to a 2023 PSU award, 3.1816 rights related to a 2024 RSU award and 0.3075 rights related to a 2025 RSU award.
- Each dividend equivalent right is economically equivalent to one share of Lemaitre Vascular's common stock and vests proportionately with the underlying award.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing regarding insider transactions, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure related to insider transactions, specifically the acquisition of dividend equivalent rights, which are common in executive compensation packages within publicly traded companies.
Stakeholder Impact
- The acquisition of dividend equivalent rights by a company director may be of interest to shareholders, as it reflects the director's stake in the company's performance.
Key Dates
| Date | Description |
|---|---|
| 12/02/2020 | Date of restricted stock unit award grant related to dividend equivalent rights. |
| 12/11/2021 | Date of restricted stock unit award grant related to dividend equivalent rights. |
| 12/12/2022 | Date of restricted stock unit and performance share unit award grants related to dividend equivalent rights. |
| 12/08/2023 | Date of restricted stock unit and performance share unit award grants related to dividend equivalent rights. |
| 12/06/2024 | Date of restricted stock unit award grant related to dividend equivalent rights. |
| 02/18/2025 | Date of restricted stock unit award grant related to dividend equivalent rights. |
| 03/27/2025 | Date of transaction: Acquisition of dividend equivalent rights. |
| 03/31/2025 | Date of signature for the Form 4 filing. |
Keywords
dividend equivalent rights, Lemaitre Vascular, Form 4, Roberts, insider trading, LMAT, RSU, PSU, director, officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.